Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Worldwide revenue
View:
Post by prested on Nov 27, 2015 12:11pm

Worldwide revenue

Places like Quebec are insignificant. 60% of sales are outside N. America. Revenues next year are forecast to be $1 billion. This is the greatest buying opportunity in the field in years IMO, and although there are sector concerns, once those come into focus and the liars, opportunists and buko artists are relegated to the garbage can where they belong, there is serious money to be made here. GLTAL
Comment by cashflow98 on Nov 27, 2015 12:23pm
I concur, I think people are forgetting the power of the pharma lobby in Washington and across America. H. Clinton opportunistically made a political 'promise' that put a spotlight on the industry. Historically, the lobbyists and big drug companies always win the day and of course it is a well known fact that politicians always keep their promises.....lol !!!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities